4basebio PLC announces RBC Capital Markets initiates research coverage
Why we think this is neutral
This is a routine regulatory announcement about RBC Capital Markets initiating research coverage on 4basebio PLC. It does not contain any material financial updates or information about the company's operations, so the sentiment is neutral.
Key Points
- RBC Capital Markets has initiated research coverage of 4basebio PLC
Summary
The biotechnology company announces that RBC Capital Markets has initiated research coverage.
4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform, announces that RBC Capital Markets has initiated research coverage of the Company, which can be found on the Company's website.
GENERAL UPDATE